Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neisseria Meningitidis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00631995
What this trial is testing

Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 360
Not applicableUnknownNCT04594785
What this trial is testing

Evaluation of Post Infectious Inflammatory Reaction (PIIR) Concerning Children After Streptococcus Pneumoniae, Streptococcus Pyogenes and Neisseria Meningococcus Invasive Infection

Who this might be right for
Streptococcus PneumoniaStreptococcus Pyogenes InfectionNeisseria Meningitides Meningitis
University Hospital, Montpellier 150
Testing effectiveness (Phase 2)Study completedNCT00471081
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 385
Not applicableStudy completedNCT01459432
What this trial is testing

Understanding Immunity Persistence After Adolescent MenC Vaccination

Who this might be right for
Antibody Persistance After Booster Dose of Men C Vaccine
University of Oxford 134
Not applicableStudy completedNCT03419533
What this trial is testing

Study to Assess Oropharyngeal Carriage of N. Meningitidis in South Australian School Leavers

Who this might be right for
Neisseria Meningitidis
University of Adelaide 6,802
Not applicableEnded earlyNCT00465582
What this trial is testing

B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors

Who this might be right for
Meningococcal Infections
University Hospital, Rouen 3,296
Large-scale testing (Phase 3)Study completedNCT01641042
What this trial is testing

Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 86
Not applicableStudy completedNCT02844088
What this trial is testing

Evaluation of Vaccinal and Natural Immunity Against Meningococcus C

Who this might be right for
Prevention of Meningococcus C Infections
University Hospital, Clermont-Ferrand 184
Large-scale testing (Phase 3)Study completedNCT00444951
What this trial is testing

Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi Arabia

Who this might be right for
Neisseria MeningitidisMeningococcal Infections
Sanofi Pasteur, a Sanofi Company 450
Large-scale testing (Phase 3)Study completedNCT01218451
What this trial is testing

NeisVac-C Single Prime Study in Infants

Who this might be right for
Neisseria Meningitidis
Pfizer 956
Not applicableStudy completedNCT00161941
What this trial is testing

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

Who this might be right for
Meningococcal Meninigitis, Serogroup C
Pfizer 321
Post-approval studies (Phase 4)Active Not RecruitingNCT06113198
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 50
Not applicableUnknownNCT05212935
What this trial is testing

A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy

Who this might be right for
VaccinationRotavirus InfectionsMeningococcal Infections
Federico II University 2,000
Post-approval studies (Phase 4)Study completedNCT01129518
What this trial is testing

Can we Reduce the Number of Vaccine Injections for Children?

Who this might be right for
Invasive Meningococcal Disease
University of Oxford 404
Large-scale testing (Phase 3)Study completedNCT00891176
What this trial is testing

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 582
Large-scale testing (Phase 3)Study completedNCT01154088
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year Olds

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,170
Large-scale testing (Phase 3)Study completedNCT03964012
What this trial is testing

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Who this might be right for
Meningococcal Meningitis
Serum Institute of India Pvt. Ltd. 1,800
Testing effectiveness (Phase 2)Study completedNCT00197795
What this trial is testing

Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle Vaccine Given in a 0,6,12 Month Schedule to Health UK Adults

Who this might be right for
Neisseria Meningitidis
Public Health England 30
Testing effectiveness (Phase 2)Study completedNCT00443157
What this trial is testing

Meningococcal B Vaccination in University Students

Who this might be right for
Neisseria Meningitidis Serogroup B
Public Health England 50
Large-scale testing (Phase 3)Study completedNCT02305446
What this trial is testing

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Novartis 55
Next Page